Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 578

Similar articles for PubMed (Select 21473655)

1.

Medication costs to private insurers of diversion of medications for attention-deficit hyperactivity disorder.

Aldridge AP, Kroutil LA, Cowell AJ, Reeves DB, Van Brunt DL.

Pharmacoeconomics. 2011 Jul;29(7):621-35. doi: 10.2165/11584590-000000000-00000.

PMID:
21473655
2.

Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies.

Wu EQ, Birnbaum HG, Zhang HF, Ivanova JI, Yang E, Mallet D.

J Manag Care Pharm. 2007 Sep;13(7):561-9.

3.

The nonmedical use of prescription ADHD medications: results from a national Internet panel.

Novak SP, Kroutil LA, Williams RL, Van Brunt DL.

Subst Abuse Treat Prev Policy. 2007 Oct 31;2:32.

4.

Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature.

Wilens TE, Adler LA, Adams J, Sgambati S, Rotrosen J, Sawtelle R, Utzinger L, Fusillo S.

J Am Acad Child Adolesc Psychiatry. 2008 Jan;47(1):21-31. doi: 10.1097/chi.0b013e31815a56f1. Review.

PMID:
18174822
5.

Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications.

Wilens TE, Gignac M, Swezey A, Monuteaux MC, Biederman J.

J Am Acad Child Adolesc Psychiatry. 2006 Apr;45(4):408-14.

PMID:
16601645
6.

The misuse and diversion of prescribed ADHD medications by college students.

Rabiner DL, Anastopoulos AD, Costello EJ, Hoyle RH, McCabe SE, Swartzwelder HS.

J Atten Disord. 2009 Sep;13(2):144-53. doi: 10.1177/1087054708320414. Epub 2009 May 15.

PMID:
19448150
7.

ADHD medication use, adherence, persistence and cost among Texas Medicaid children.

Barner JC, Khoza S, Oladapo A.

Curr Med Res Opin. 2011;27 Suppl 2:13-22. doi: 10.1185/03007995.2011.603303.

PMID:
21973228
8.

Cost effectiveness of pharmacotherapies for attention-deficit hyperactivity disorder: a systematic literature review.

Wu EQ, Hodgkins P, Ben-Hamadi R, Setyawan J, Xie J, Sikirica V, Du EX, Yan SY, Erder MH.

CNS Drugs. 2012 Jul 1;26(7):581-600. doi: 10.2165/11633900-000000000-00000. Review.

PMID:
22712698
9.

The use, misuse and diversion of prescription stimulants among middle and high school students.

McCabe SE, Teter CJ, Boyd CJ.

Subst Use Misuse. 2004 Jun;39(7):1095-116.

PMID:
15387205
10.
11.

Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children.

Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Muriel AC, Frank RG.

Arch Gen Psychiatry. 2005 Apr;62(4):435-41.

12.

Second opinions improve ADHD prescribing in a medicaid-insured community population.

Thompson JN, Varley CK, McClellan J, Hilt R, Lee T, Kwan AC, Lee T, Trupin E.

J Am Acad Child Adolesc Psychiatry. 2009 Jul;48(7):740-8. doi: 10.1097/CHI.0b013e3181a2b2ed.

PMID:
19465882
13.

Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000.

Birnbaum HG, Kessler RC, Lowe SW, Secnik K, Greenberg PE, Leong SA, Swensen AR.

Curr Med Res Opin. 2005 Feb;21(2):195-206.

PMID:
15801990
14.

Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.

Winterstein AG, Gerhard T, Shuster J, Zito J, Johnson M, Liu H, Saidi A.

Ann Pharmacother. 2008 Jan;42(1):24-31. Epub 2007 Nov 27.

PMID:
18042808
15.

Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD.

Jensen PS, Garcia JA, Glied S, Crowe M, Foster M, Schlander M, Hinshaw S, Vitiello B, Arnold LE, Elliott G, Hechtman L, Newcorn JH, Pelham WE, Swanson J, Wells K.

Am J Psychiatry. 2005 Sep;162(9):1628-36.

PMID:
16135621
17.

The diversion and misuse of pharmaceutical stimulants: what do we know and why should we care?

Kaye S, Darke S.

Addiction. 2012 Mar;107(3):467-77. doi: 10.1111/j.1360-0443.2011.03720.x. Review.

PMID:
22313101
18.

Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder.

Secnik K, Swensen A, Lage MJ.

Pharmacoeconomics. 2005;23(1):93-102.

PMID:
15693731
19.

Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.

Sikirica V, Pliszka SR, Betts KA, Hodgkins P, Samuelson T, Xie J, Erder H, Dammerman R, Robertson B, Wu EQ.

J Manag Care Pharm. 2012 Nov-Dec;18(9):676-89.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk